MAGRAB E. BRENDAN 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 15, 2018
Insider Transaction Report
Form 4
MAGRAB E. BRENDAN
DirectorChairman of the Board
Transactions
- Award
Common Stock Options
2018-03-13+345,000→ 345,000 totalExercise: $0.27From: 2019-03-13Exp: 2028-03-13→ Common Stock (345,000 underlying)
Footnotes (1)
- [F1]These options were granted subject to the approval of the majority stockholder of the registrant pursuant to an agreement between the majority stockholder and the registrant. In the event that the majority stockholder does not approve the option grant, the options will be canceled.